XOMA 052, an once-a-month injection to treat diabetes, is undergoing Phase 2b dose-ranging clinical trial.
Athersys, Inc has been granted patent in US for stem cell technology that has potential to treat heart attack, stroke, inflammatory bowel disease etc.
India is planning to revise the clinical trial registry in accordance with the norms stipulated by he World Health Organisation (WHO), reports said.
MoxDuo, a morphine plus oxycodone combination drug to treat severe pain, is currently in late-phase clinical studies, announced QRxPharma Limited.
The German drug major Bayer AG is planning to move India's Supreme Court seeking protection for its Nexavar (sorafenib) even as Cipla prepares for the launch of a generic version of the kidney cancer drug in a couple of months time following the Delhi High Court's latest verdict upholding an earlier judgment in the case.